» Articles » PMID: 34680797

Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials

Overview
Specialty Pharmacology
Date 2021 Oct 23
PMID 34680797
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Mycoplasma infections are frequent in humans, as well as in a broad range of animals. However, antimicrobial treatment options are limited, partly due to the lack of a cell wall in these peculiar bacteria. Both veterinary and human medicines are facing increasing resistance prevalence for the most commonly used drugs, despite different usage practices. To date, very few reviews have integrated knowledge on resistance to antimicrobials in humans and animals, the latest dating back to 2014. To fill this gap, we examined, in parallel, antimicrobial usage, resistance mechanisms and either phenotype or genotype-based methods for antimicrobial susceptibility testing, as well as epidemiology of resistance of the most clinically relevant human and animal mycoplasma species. This review unveiled common features and differences that need to be taken into consideration in a "One Health" perspective. Lastly, two examples of critical cases of multiple drug resistance are highlighted, namely, the human and the animal species, both of which can lead to the threat of untreatable infections.

Citing Articles

Comparison of growth performance, oxidative stress, and intestinal microbiota of rockfish (Sebastiscus marmoratus) in different culture modes.

Wang Q, Ruan Z, Wang Y, Zhang Y, Chai X Fish Physiol Biochem. 2025; 51(2):54.

PMID: 39994088 DOI: 10.1007/s10695-025-01450-w.


Differences in gut microbiota composition, diversity, and predicted functional activity between wild and captive zoo Carollia perspicillata in a One Health perspective.

Popov I, Popov I, Chebotareva I, Tikhmeneva I, Peshkova D, Krikunova A Braz J Microbiol. 2025; .

PMID: 39961999 DOI: 10.1007/s42770-025-01630-z.


Chronic osteomyelitis with pathological fracture induced by infection: a case report and review of the literature.

Zhu L, Shen W, Zou X, Zuo J, Xiao N Front Med (Lausanne). 2025; 12:1510753.

PMID: 39931564 PMC: 11807816. DOI: 10.3389/fmed.2025.1510753.


: not a typical respiratory pathogen.

Rowlands R, Meyer Sauteur P, Beeton M, The Escmid Study Group For Mycoplasma And Chlamydia Infections Esgmac J Med Microbiol. 2024; 73(10).

PMID: 39475213 PMC: 11523975. DOI: 10.1099/jmm.0.001910.


Interaction between bacterial microbiota and nematode parasite communities in sheep's gastrointestinal tract.

Mate L, Alvarez L, Lloberas M, Imperiale F, Lanusse C, Liron J PLoS One. 2024; 19(6):e0306390.

PMID: 38935803 PMC: 11210874. DOI: 10.1371/journal.pone.0306390.


References
1.
Watanabe M, Hitomi S, Goto M, Hasegawa Y . Bloodstream infection due to Mycoplasma arginini in an immunocompromised patient. J Clin Microbiol. 2012; 50(9):3133-5. PMC: 3421792. DOI: 10.1128/JCM.00736-12. View

2.
Neimark H, Hoff B, Ganter M . Mycoplasma ovis comb. nov. (formerly Eperythrozoon ovis), an epierythrocytic agent of haemolytic anaemia in sheep and goats. Int J Syst Evol Microbiol. 2004; 54(Pt 2):365-371. DOI: 10.1099/ijs.0.02858-0. View

3.
Sweeney M, Lubbers B, Schwarz S, Watts J . Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens. J Antimicrob Chemother. 2018; 73(6):1460-1463. DOI: 10.1093/jac/dky043. View

4.
Godinho K, Rae A, Windsor G, Tilt N, Rowan T, Sunderland S . Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves. Vet Ther. 2005; 6(2):96-112. View

5.
White C, Jewer D . Seal finger: A case report and review of the literature. Can J Plast Surg. 2010; 17(4):133-5. PMC: 2827281. DOI: 10.1177/229255030901700415. View